Sham surgery is a fake operation designed to mimic a real surgical procedure without performing the therapeutic step that’s supposed to help. It’s the surgical equivalent of a sugar pill. Researchers use it in clinical trials to determine whether a surgery actually works or whether patients improve simply because they believe they’ve been operated on.
How Sham Surgery Works
In a sham-controlled trial, patients are randomly assigned to receive either the real surgery or a convincing imitation. The sham procedure replicates every part of the experience: the pre-surgery routine, anesthesia, skin incisions if necessary, time in the operating room, and post-surgery follow-up. The only thing omitted is the specific step believed to be therapeutically necessary. Patients in both groups don’t know which procedure they received.
In some trials, a surgeon inserts a scope into the body but performs no repair. In others, small incisions are made in the skin and then closed. The goal is to make the experience indistinguishable from the real thing so that any difference in outcomes between the two groups can be attributed to the surgery itself, not to the powerful psychological effects of going through an operation.
Why It Exists: The Surgical Placebo Effect
Surgery produces a placebo effect just like pills do. The placebo response in surgical patients can account for up to 35 percent of the improvement they experience. Part of this comes from the surgeon-patient relationship, part from the ritual and perceived seriousness of an operation, and part from straightforward neuroscience: when people expect pain relief, the brain releases its own natural painkillers (endogenous opioids and endocannabinoids) and triggers dopamine in reward centers. Expectation of improvement can also redirect attention away from pain, providing real, measurable relief even when nothing therapeutic has been done.
This creates a serious problem for evaluating surgeries. If a patient feels better after an operation, it’s difficult to know whether the procedure itself helped or whether the elaborate experience of surgery triggered the body’s own healing responses. Without a sham control group, surgical studies can dramatically overestimate how well a procedure works.
The Knee Surgery Trial That Changed the Debate
The most famous sham surgery study was published in the New England Journal of Medicine in 2002. Researchers enrolled 180 patients with knee osteoarthritis and randomly assigned them to one of three groups: arthroscopic cleaning of the joint, arthroscopic rinsing of the joint, or a sham procedure where small skin incisions were made but nothing was done inside the knee.
The results were striking. At no point during the two-year follow-up did either real surgery group report less pain or better function than the sham group. Pain scores at two years were virtually identical across all three groups. The 95 percent confidence intervals ruled out even a clinically meaningful difference. The blinding worked, too: at two weeks post-surgery, only about 14 percent of sham patients guessed they’d received the fake procedure, roughly the same percentage as in the real surgery groups.
This trial upended orthopedic practice. Arthroscopic knee surgery for osteoarthritis had been one of the most commonly performed operations in the United States, and this study showed it was no better than doing nothing at all beyond making incisions in the skin.
When Sham Trials Confirm a Surgery Works
Sham-controlled trials don’t always debunk procedures. A notable example is the ORBITA-2 trial, also published in the New England Journal of Medicine, which tested whether heart stenting (percutaneous coronary intervention) actually reduces chest pain in patients with stable angina. In this trial, 301 patients underwent cardiac catheterization, and roughly half received a real stent while the other half had the catheter inserted but no stent placed.
At 12 weeks, the stenting group had significantly lower angina symptom scores (2.9 versus 5.6 on a scale where higher numbers mean worse symptoms). This confirmed that stenting genuinely reduces chest pain beyond the placebo effect, giving both doctors and patients stronger confidence in the procedure.
Risks to Participants
The core ethical tension of sham surgery is straightforward: participants in the sham group are exposed to real risks with no chance of therapeutic benefit. Depending on the trial, that can include general anesthesia, sedation, skin incisions, infection risk, and recovery time. All of these carry some degree of danger, and the sham group endures them solely to produce better scientific data.
Participants are told during the consent process that they may receive the sham procedure rather than the real one. The informed consent explains that the sham mimics the actual operation in every way but omits the therapeutic step. Researchers also explain why the sham control is necessary and what risks it involves. Still, the ethics of exposing patients to surgical risks without potential benefit remains one of the most debated questions in clinical research.
The Ethical Debate
Medical ethics guidelines aren’t fully settled on sham surgery. The Declaration of Helsinki, the foundational document for research ethics, states that “the health of my patient will be my first consideration,” a principle that sits uneasily with exposing sham-group patients to surgical risk for no personal benefit. Some ethicists argue this principle was written for clinical care, not research, and that different standards should apply when the goal is generating knowledge that benefits future patients.
In practice, most ethics review boards approve sham-controlled surgical trials only when specific conditions are met: the risks of the sham procedure are low, the surgery being tested is already widely performed without strong evidence, and there’s no less invasive way to answer the scientific question. Trials involving minimal procedures like arthroscopy or catheterization are more likely to be approved than those requiring major incisions or prolonged anesthesia.
Why Sham Controls Are Still Rare
Despite their scientific value, sham-controlled surgical trials remain uncommon. Most surgeries enter clinical practice without ever being tested against a sham. The reasons are partly practical: these trials are expensive, logistically complex, and difficult to recruit for. They also face resistance from surgeons, who may be reluctant to perform procedures they know won’t help, and from patients, who may not want to risk receiving a fake operation.
Regulatory agencies have taken a cautious approach. The FDA uses sham controls more commonly in device approval than in surgical technique evaluation, but even then, the agency acknowledges that alternative study designs may be appropriate in certain circumstances, such as diseases with high mortality or predictable symptom patterns. The result is that many surgical procedures are adopted based on comparison with non-surgical treatments rather than sham controls, leaving open the question of how much of their benefit comes from the procedure itself versus the powerful act of being operated on.